The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Screen failure rates in contemporary phase II/III therapeutic trials in genitourinary malignancies.
 
Sarah E. Wong
No Relationships to Disclose
 
Scott A. North
Honoraria - Astellas Pharma; Janssen-Ortho; Novartis; Pfizer
 
Christopher Sweeney
Stock and Other Ownership Interests - BIND Biosciences; Leuchemix
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; BIND Biosciences; Genentech/Roche; Janssen Biotech; Sanofi
Research Funding - Astellas Pharma (Inst); Exelixis (Inst); Janssen Biotech (Inst)
Patents, Royalties, Other Intellectual Property - Leuchemix, Parthenolide, Dimethylaminoparthenolide. Exelixis: Abiraterone plus cabozantinib combination
 
Martin R. Stockler
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Bionomics (Inst); Celgene (Inst); Medivation (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Astellas Pharma
 
Srikala S. Sridhar
Consulting or Advisory Role - Astellas Pharma (Inst); Bayer (Inst); Janssen (Inst); Sanofi (Inst)
Research Funding - Sanofi (Inst)